AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Domain-Adapted AI Gains Attention for Psychiatric Clinical Support
Bioengineer.org reports on a domain-adapted AI approach aimed at psychiatric clinical support. The work suggests that specialization may be more useful than generic chatbot behavior in mental health settings.
Mental Health LLMs Need More Than Guardrails, Fast Company Says
Fast Company argues that large language models still fail in mental health use cases and require a two-pronged fix. The piece reflects mounting concern that general-purpose chat systems are being used in contexts they were never designed to safely serve.
New Zealand Extends National AI Scribe Rollout to Emergency Mental Health Teams
New Zealand is expanding its national AI scribe deployment in public emergency departments to include mental health crisis teams, with 1,000 additional licenses planned. The development is notable because it shows AI documentation tools moving into one of healthcare’s most sensitive settings, where productivity gains must be weighed against privacy, trust, and clinical nuance.
JAMA Spotlights the Surge of AI Chatbots as Mental Health Support Tools
A January JAMA news feature examined the rapid rise of generative AI chatbots as a de facto source of mental health support in the U.S., emphasizing both their scale and the weak evidence base behind many tools. The piece stands out because it captures the central tension in AI mental health today: soaring consumer adoption alongside unsettled clinical, ethical, and regulatory standards.
The First Trial of Generative AI Therapy Shows It Might Help With Depression
MIT Technology Review examines the Dartmouth Therabot trial — the first rigorous test of generative AI for mental health treatment — and what its promising results mean for the future of therapy access.
First Randomized Trial of Generative AI Therapy Chatbot Shows Significant Mental Health Benefits
Dartmouth researchers conducted the first-ever randomized controlled trial of a generative AI therapy chatbot called Therabot. Participants with depression saw a 51% reduction in symptoms, while those with anxiety experienced a 31% reduction over four weeks.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.